Table 2 Assessment of Association between Patient Comorbidities and Survival for Adult COVID-19 Patients Admitted to the Public Hospitals in Al Ain, the Eastern Region of the United Arab Emirates
From: Assessment of mortality from COVID-19 in a multicultural multi-ethnic patient population
Comorbidity | Category | Outcome | P value | |||
|---|---|---|---|---|---|---|
Survived | Deceased | |||||
n | % | n | % | |||
Kidney disease | No | 2716 | 97.6 | 68 | 2.4 |  < 0.001 |
Yes | 83 | 80.6 | 20 | 19.4 | ||
Heart disease | No | 2651 | 97.3 | 74 | 2.7 |  < 0.001 |
Yes | 148 | 91.4 | 14 | 8.6 | ||
Diabetes Mellitus | No | 2069 | 97.9 | 45 | 2.1 |  < 0.001 |
| Â | Yes | 730 | 94.4 | 43 | 5.6 | Â |
Hypertension | No | 2100 | 97.6 | 52 | 2.4 |  < 0.001 |
Yes | 699 | 95.1 | 36 | 4.9 | ||
Respiratory disease | No | 2681 | 97.1 | 81 | 2.9 | Not significant |
Yes | 118 | 94.4 | 7 | 5.6 | ||
Hematology | No | 2781 | 97 | 87 | 3 | Not significant |
Yes | 18 | 94.7 | 1 | 5.3 | ||
Immunocompromised | No | 2727 | 97 | 83 | 3 | Not significant |
Yes | 72 | 93.5 | 5 | 6.5 | ||
Liver Disease | No | 2792 | 97 | 87 | 3 | Not significant |
Yes | 7 | 87.5 | 1 | 12.5 | ||
Obesity | No | 2706 | 97 | 83 | 3 | Not significant |
Yes | 93 | 94.9 | 5 | 5.1 | ||